Table I.
Survey respondent and pediatric atopic dermatitis population characteristics
| Question | Responses | Frequency, n (%) |
|---|---|---|
| Which one of the following best describes your primary practice type (>50% of your clinical time)? | Academic hospital | 12 (80.0) |
| Academic community practice | 1 (6.7) | |
| Community private practice | 2 (13.3) | |
| How many years have you been in practice? | <5 y | 3 (20.0) |
| 5-10 y | 3 (20.0) | |
| 11-15 y | 2 (13.3) | |
| 16-30 y | 5 (33.3) | |
| >30 y | 2 (13.3) | |
| What is your specialty? | Dermatology | 5 (33.3) |
| Pediatric dermatology | 9 (60.0) | |
| Pediatrics | 1 (6.7) | |
| Allergy/immunology | 0 (0) | |
| How many patients with atopic dermatitis do you see in an average month? | <10 | 0 (0%) |
| >10 and <50 | 4 (26.7) | |
| >50 and <75 | 4 (26.7) | |
| >75 and <100 | 4 (26.7) | |
| >100 | 3 (20.0) | |
| What percentage of your moderate-to-severe patients with AD are?∗ | Infants (2 mo-2 y): | 26 |
| Preschool children (3-5 y): | 26 | |
| Children (6-11 y): | 27 | |
| Adolescent (12 y-18 y): | 17 | |
| How do you define “moderate-to-severe AD” in your patient population (check all that apply)? | Gestalt | 11 (73.3) |
| Validated tools/instruments | 12 (80.0) | |
| Patient-reported outcomes | 9 (60.0) | |
| Other (please specify)† | 3 (20.0) |
AD, Atopic dermatitis.
∗
Two respondents’ selections did not add to 100%, presumably because they also treat adults.
†
“Other” responses specified included: “clinical opinion"; "impact on QoL, level of pruritus, level of medications utilized"; and "gestalt taking into account body surface involvement, number of skin infections, presence of lichenification, and impact on quality of life.”